HIV/AIDS in 2024: Global Statistics, Transmission, and Ending the Epidemic

Human Immunodeficiency Virus (HIV) remains a major global health challenge. Since the epidemic began, an estimated 85 million people have acquired HIV, and 40 million have died from AIDS-related illnesses.

Global Snapshot (UNAIDS 2023 Data)

  • People Living with HIV (PLHIV): 39.0 million (2022)
  • New Infections: 1.3 million (2022)
  • AIDS-Related Deaths: 630,000 (2022)
  • Access to ART: 29.8 million (76% of PLHIV)
  • Viral Suppression: 71% of PLHIV

Transmission Routes

  • Sexual contact (vaginal, anal) – ~85% globally
  • Perinatal (mother-to-child): pregnancy, delivery, breastfeeding
  • Blood exposure: sharing injection equipment, unsafe medical injections, transfusion (rare in screened supplies)
  • NOT transmitted by: casual contact, saliva, sweat, tears, insects, shared utensils/toilets.

Key Populations at Higher Risk

  • Men who have sex with men (MSM)
  • People who inject drugs (PWID)
  • Sex workers and clients
  • Transgender people
  • Prisoners
  • Adolescent girls and young women in sub-Saharan Africa

Persistent Challenges

  • Treatment Gaps: 9.2 million PLHIV not on ART; children especially underserved (57% coverage).
  • Stigma and Discrimination: Barriers to testing, care, retention; internalized stigma.
  • Funding Shortfalls: $8.5 billion gap for 2025 targets.
  • Drug Resistance: Pre-treatment NNRTI resistance >10% in several regions; need for DTG-based regimens.
  • Co-morbidities: TB, viral hepatitis, NCDs, mental health.
  • No Cure/Vaccine: Research ongoing (broadly neutralizing antibodies, mRNA vaccines, latency-reversing agents).

Ending the Epidemic: 95-95-95 Targets (2025)

  1. 95% of PLHIV know their status
  2. 95% of diagnosed on ART
  3. 95% on ART virally suppressed

Achieving these requires differentiated service delivery, community-led responses, integration with primary care, and sustained political and financial commitment.

HIV & AIDS - Related Articles